Sign in

CIK 0001314102

  • Non-accelerated filer
  • Smaller reporting company

EyePoint, Inc.

Sign in to watch
Ticker
EYPT
Exchange
Nasdaq
Industry
Laboratory Analytical Instruments
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
262774444
Phone
+1 617-926-5000
Business address
480 PLEASANT STREET, SUITE C400, WATERTOWN, MA, 02472
Former names
EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-12-05 Liu Ye Director Sale −733,758 $19.91 $14.6M 2,276,963
2023-12-04 Pine Michael Craig Chief Corp Dev.&Strat. Officer Option exercise 10b5-1 +45,000 $12.62 $568K 50,343
2023-12-04 Pine Michael Craig Chief Corp Dev.&Strat. Officer Sale 10b5-1 −45,000 $22.00 $990K 5,343
2023-12-04 Pine Michael Craig Chief Corp Dev.&Strat. Officer Sale 10b5-1 −1,000 $20.79 $21K 4,343
2023-12-04 Pine Michael Craig Chief Corp Dev.&Strat. Officer Option exercise · Stock Option (Right to Buy) 10b5-1 −45,000 55,000
2023-12-04 Pine Michael Craig Chief Corp Dev.&Strat. Officer Option exercise 10b5-1 +45,000 $12.62 $568K 50,343
2023-12-04 Pine Michael Craig Chief Corp Dev.&Strat. Officer Sale 10b5-1 −45,000 $22.00 $990K 5,343
2023-12-04 Pine Michael Craig Chief Corp Dev.&Strat. Officer Option exercise · Stock Option (Right to Buy) 10b5-1 −45,000 55,000
2023-12-04 Paggiarino Dario A. Chief Medical Officer Option exercise 10b5-1 +30,625 $10.13 $310K 56,332
2023-12-04 Paggiarino Dario A. Chief Medical Officer Sale 10b5-1 −30,625 $22.00 $674K 25,707
2023-12-04 Paggiarino Dario A. Chief Medical Officer Option exercise · Stock Option (Right to Buy) 10b5-1 −30,625 39,375
2023-12-04 Lurker Nancy Executive Vice Chair Sale 10b5-1 −20,000 $20.76 $415K 170,559
2023-12-04 Cormorant Asset Management, LP 10% owner Purchase +321,259 $18.80 $6.0M 3,852,202
2023-12-04 Cormorant Asset Management, LP 10% owner Purchase +945,664 $19.88 $18.8M 4,797,866
2023-12-04 Cormorant Asset Management, LP 10% owner Purchase +122,625 $20.62 $2.5M 4,920,491
2023-12-04 Cormorant Asset Management, LP 10% owner Purchase +79,805 $21.87 $1.7M 5,000,296
2023-12-04 Cormorant Asset Management, LP 10% owner Purchase +28,090 $22.80 $640K 5,028,386
2023-12-04 Cormorant Asset Management, LP 10% owner Purchase +37,081 $24.01 $890K 5,065,467
2023-12-04 Cormorant Asset Management, LP 10% owner Purchase +39,899 $24.87 $992K 5,105,366
2023-12-04 Cormorant Asset Management, LP 10% owner Purchase +65,086 $25.88 $1.7M 5,170,452

Page 20 of 31 · 616 trades